2021 Q3 Form 10-Q Financial Statement
#000109181821000105 Filed on August 06, 2021
Income Statement
Concept | 2021 Q3 | 2021 Q2 | 2020 Q2 |
---|---|---|---|
Revenue | |||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $20.02K | $27.60K | $3.300K |
YoY Change | 506.79% | 736.48% | |
Operating Profit | -$20.02K | -$27.60K | -$3.300K |
YoY Change | 736.48% | ||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | |||
YoY Change | |||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$20.02K | -$27.60K | -$3.300K |
YoY Change | 506.79% | 736.48% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | ||
Diluted Earnings Per Share | |||
COMMON SHARES | |||
Basic Shares Outstanding | 47.23M shares | 87.23M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q3 | 2021 Q2 | 2020 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $1.700K | $1.700K | $1.700K |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $1.700K | ||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | ||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $1.700K | ||
Total Long-Term Assets | $0.00 | ||
Total Assets | $1.700K | ||
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $10.95K | ||
YoY Change | |||
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $10.95K | ||
Total Long-Term Liabilities | |||
Total Liabilities | $10.95K | ||
YoY Change | |||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$168.4K | ||
YoY Change | |||
Common Stock | $87.23K | ||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$5.400K | -$9.254K | -$96.20K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.700K | ||
YoY Change |
Cashflow Statement
Concept | 2021 Q3 | 2021 Q2 | 2020 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$20.02K | -$27.60K | -$3.300K |
YoY Change | 506.79% | 736.48% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | |||
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | |||
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | |||
Cash From Investing Activities | |||
Cash From Financing Activities | |||
Net Change In Cash | |||
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | |||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
GOLD ROCK HOLDINGS, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity File Number
EntityFileNumber
|
000-51074 | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-0434297 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2020 General Booth Blvd | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 230 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Virginia Beach | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
VA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
23454 | ||
dei |
City Area Code
CityAreaCode
|
757 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
306-6090 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
No | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2021Q2 | us-gaap |
Cash
Cash
|
1700 | USD |
CY2020Q4 | us-gaap |
Cash
Cash
|
1700 | USD |
CY2021Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
USD | |
CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
100 | USD |
CY2021Q2 | us-gaap |
Assets Current
AssetsCurrent
|
1700 | USD |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1800 | USD |
CY2021Q2 | us-gaap |
Assets
Assets
|
1700 | USD |
CY2021Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6954 | USD |
CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
14000 | USD |
CY2021Q2 | us-gaap |
Liabilities
Liabilities
|
10954 | USD |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
104000 | USD |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
87227500 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
87227500 | shares |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47227500 | shares |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47227500 | shares |
CY2021Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
87227 | USD |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
47227 | USD |
CY2021Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
71923 | USD |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
-41927 | USD |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-168404 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-107500 | USD |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9254 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102200 | USD |
CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1700 | USD |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1800 | USD |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27604 | USD |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3300 | USD |
us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
30000 | USD | |
us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
30000 | USD | |
CY2020Q4 | grhi |
Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
|
90000 | USD |
CY2021Q2 | grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
3000 | USD |
CY2020Q2 | grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
3000 | USD |
CY2021Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
47227500 | shares |
CY2020Q4 | us-gaap |
Assets
Assets
|
1800 | USD |
grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
6000 | USD | |
grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
6000 | USD | |
CY2021Q2 | grhi |
Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
|
4000 | USD |
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000894501 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
CY2021Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10954 | USD |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
104000 | USD |
CY2021Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
USD | |
CY2020Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
USD | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
USD | ||
us-gaap |
Cost Of Revenue
CostOfRevenue
|
USD | ||
CY2021Q2 | us-gaap |
Revenues
Revenues
|
USD | |
CY2020Q2 | us-gaap |
Revenues
Revenues
|
USD | |
us-gaap |
Revenues
Revenues
|
USD | ||
us-gaap |
Revenues
Revenues
|
USD | ||
CY2021Q2 | us-gaap |
Gross Profit
GrossProfit
|
USD | |
CY2020Q2 | us-gaap |
Gross Profit
GrossProfit
|
USD | |
us-gaap |
Gross Profit
GrossProfit
|
USD | ||
us-gaap |
Gross Profit
GrossProfit
|
USD | ||
CY2021Q2 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
USD | |
CY2020Q2 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
USD | |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
24604 | USD |
CY2020Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
300 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
24904 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
600 | USD | |
CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
27604 | USD |
CY2020Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
3300 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
60904 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
36600 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-60904 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-36600 | USD | |
CY2021Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
87227500 | shares |
CY2020Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
47227500 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
68884959 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
47227500 | shares | |
CY2021Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2020Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-60904 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-36600 | USD | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
3000 | USD | |
grhi |
Issuance Of Stock And Warrants For Services Or Claims1
IssuanceOfStockAndWarrantsForServicesOrClaims1
|
USD | ||
grhi |
Issuance Of Stock And Warrants For Services Or Claims1
IssuanceOfStockAndWarrantsForServicesOrClaims1
|
29000 | USD | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
USD | ||
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
-100 | USD | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
USD | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
6954 | USD | |
CY2021Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
87227500 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
87227500 | shares |
grhi |
Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
|
-4000 | USD | |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
5600 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-60904 | USD | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9254 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
us-gaap |
Interest Paid
InterestPaid
|
USD | ||
us-gaap |
Interest Paid
InterestPaid
|
USD | ||
grhi |
Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
|
-30000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-17850 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | ||
us-gaap |
Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
|
17850 | USD | |
us-gaap |
Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
|
1000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
17850 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1000 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD | ||
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
USD | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
USD | ||
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-60600 | USD |
grhi |
Capital Contributions Director
CapitalContributionsDirector
|
1000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-36600 | USD | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-96200 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102200 | USD |
grhi |
Stock Issued During Period Value For Accrued Expenses Directors Fees
StockIssuedDuringPeriodValueForAccruedExpensesDirectorsFees
|
104000 | USD | |
grhi |
Stock Issued During Period Value For Consulting And Director Compensation
StockIssuedDuringPeriodValueForConsultingAndDirectorCompensation
|
32000 | USD | |
grhi |
Capital Contributions Director
CapitalContributionsDirector
|
17850 | USD | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-93200 | USD |
CY2020Q2 | grhi |
Capital Contributions Director
CapitalContributionsDirector
|
300 | USD |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3300 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-96200 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
600 | USD |
CY2021Q2 | grhi |
Capital Contributions Director
CapitalContributionsDirector
|
17750 | USD |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27604 | USD |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9254 | USD |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p> | ||
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47227500 | shares |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47227500 | shares |
us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
17850 | USD | |
us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
1000 | USD | |
grhi |
Increase Decrease In Additional Paid In Capital
IncreaseDecreaseInAdditionalPaidInCapital
|
17850 | USD | |
grhi |
Increase Decrease In Additional Paid In Capital
IncreaseDecreaseInAdditionalPaidInCapital
|
1000 | USD | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |